Search

Your search keyword '"Montcuquet, A"' showing total 558 results

Search Constraints

Start Over You searched for: Author "Montcuquet, A" Remove constraint Author: "Montcuquet, A"
558 results on '"Montcuquet, A"'

Search Results

1. Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

2. Coencapsulation of Immunosuppressive Drug with Anti-Inflammatory Molecule in Pickering Emulsions as an Innovative Therapeutic Approach for Inflammatory Dermatoses

3. Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology

6. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

7. Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal

8. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

9. The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

12. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

13. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

18. “Co-encapsulation of Immunosuppressive Drug with Anti-inflammatory Molecule in Pickering Emulsions as a Novel Therapeutic Approach for Inflammatory Dermatoses”

19. Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study

20. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

21. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies

22. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

23. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

25. Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

26. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

29. Prévalence et prise en charge de la douleur chez les patients présentant un cancer métastatique en Franche-Comté

30. Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease

31. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

33. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

34. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

35. Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

36. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

37. Time to steroids impacts visual outcome of optic neuritis in MOGAD

38. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

39. Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society

46. Time to steroids impacts visual outcome of optic neuritis in MOGAD

48. Untreated patients with multiple sclerosis: A study of French expert centers

Catalog

Books, media, physical & digital resources